Jeffrey Scott Sherman Neogenomics Inc (NEO) insider trading activity

Jeffrey Scott Sherman is Chief Financial Officer of NEOGENOMICS INC. Currently has a direct ownership of 135,500 shares of NEO, which is worth approximately $2.08 Million. The most recent transaction as insider was on May 11, 2024, when has been sold 3,167 shares (Common Stock) at a price of $14.86 per share, resulting in proceeds of $47,061. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K

0% 3M change

1.26% 12M change

Total Value Held $2.08 Million

Jeffrey Scott Sherman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 11 2024	SELL Payment of exercise price or tax liability	$47,061 $14.86 p/Share	3,167 Reduced 2.28%	135,500 Common Stock
May 11 2024	BUY Exercise of conversion of derivative security	-	26,010 Added 14.9%	148,505 Common Stock
Dec 07 2023	SELL Payment of exercise price or tax liability	-	8,147 Reduced 6.09%	125,662 Common Stock
Dec 05 2022	BUY Grant, award, or other acquisition	-	133,809 Added 50.0%	133,809 Common Stock

Also insider at

PRVA

Privia Health Group, Inc. Healthcare

EVP, CFO and CAO

JSS